SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation on August 12, 2003. The filing serves to announce consolidated financial results for the transitional fiscal year ended May 25, 2003. The document incorporates a press release (Exhibit 99.1) containing the detailed results. Note: The request metadata references "LIFECORE BIOMEDICAL, INC.", but the filing text explicitly identifies the registrant as Landec Corporation.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1), which is referenced but not included in the input text.
Material Changes
The filing does not provide specific data regarding material changes versus prior periods. It only confirms the issuance of results for the transitional fiscal year.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information contained in the Form 8-K and Exhibit 99.1 should not be deemed "filed" for purposes of the Securities Exchange Act of 1934, nor incorporated by reference into other filings. No specific guidance, outlook, or risk factors are detailed in the provided text.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net income, EPS) in the attached Exhibit 99.1 press release.
- Confirm the details of the "transitional fiscal year" ending May 25, 2003, to understand the reporting period length.
- Review the full press release for any management commentary or forward-looking statements not captured in this summary.
- Clarify the relationship between the request metadata (Lifecore Biomedical) and the filing registrant (Landec Corporation).